首页 > 最新文献

Chinese Journal of Plastic and Reconstructive Surgery最新文献

英文 中文
A two-step correction of a congenital alar cleft in an adult patient: A case report 对一名成年患者的先天性腭裂进行两步矫正:病例报告
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.11.002
Yinmin Wang , Shikun Cao , Jun Yang , Xusong Luo
This report describes a two-step surgical correction of an isolated left-sided congenital alar cleft in a 21-year-old male patient presenting with a 9 ​× ​6.5 mm2-sized cleft. Malformations of the alar structure and displacement of the lower lateral cartilage were observed. All flaps survived, and the patient was completely satisfied with the surgical results. This surgical treatment is simple and reliable, can greatly improve the nasal appearance of patients with alar clefts, and may be an alternative to the current surgical treatment.
本报告描述了一名21岁男性患者的两步手术矫正孤立的左侧先天性鼻翼裂,其大小为9 × 6.5 mm2。观察到鼻翼结构畸形和下外侧软骨移位。所有皮瓣均成活,患者对手术结果非常满意。该手术治疗简单可靠,可大大改善鼻翼裂患者的鼻部外观,可能是目前手术治疗的替代方法。
{"title":"A two-step correction of a congenital alar cleft in an adult patient: A case report","authors":"Yinmin Wang ,&nbsp;Shikun Cao ,&nbsp;Jun Yang ,&nbsp;Xusong Luo","doi":"10.1016/j.cjprs.2023.11.002","DOIUrl":"10.1016/j.cjprs.2023.11.002","url":null,"abstract":"<div><div>This report describes a two-step surgical correction of an isolated left-sided congenital alar cleft in a 21-year-old male patient presenting with a 9 ​× ​6.5 mm<sup>2</sup>-sized cleft. Malformations of the alar structure and displacement of the lower lateral cartilage were observed. All flaps survived, and the patient was completely satisfied with the surgical results. This surgical treatment is simple and reliable, can greatly improve the nasal appearance of patients with alar clefts, and may be an alternative to the current surgical treatment.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 182-184"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139293962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasal implants for drug delivery: Advancements and applications 用于给药的鼻植入物:进展和应用
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.09.004
Hiti, Sanshita, Inderbir Singh
Nasal implants have emerged as a pioneering technology for nasal drug delivery systems. These are breakthrough options made of biocompatible materials that are temporarily inserted into the nasal passages for both functional and cosmetic purposes. Drug-eluting nasal implants are beneficial for improving patient compliance, reducing the need for repeated drug administration, and achieving controlled release of therapeutic agents. This article offers a comprehensive insight into nasal implants and their applications, and addresses a patent perspective in the same context. Important considerations for clinically approved implants, such as Propel, Sinuva, Sinu-Foam, and Relieva Stratus, have also been discussed.
鼻植入物已经成为鼻腔给药系统的一项开创性技术。这些是突破性的选择,由生物相容性材料制成,暂时插入鼻道,既有功能又有美容目的。药物洗脱鼻腔植入物有利于提高患者依从性,减少重复给药的需要,并实现治疗药物的控释。本文提供了一个全面的见解,鼻腔植入物及其应用,并解决了专利的角度来看,在相同的背景下。对于临床批准的植入物,如Propel、Sinuva、Sinu-Foam和Relieva Stratus,也讨论了重要的考虑因素。
{"title":"Nasal implants for drug delivery: Advancements and applications","authors":"Hiti,&nbsp;Sanshita,&nbsp;Inderbir Singh","doi":"10.1016/j.cjprs.2023.09.004","DOIUrl":"10.1016/j.cjprs.2023.09.004","url":null,"abstract":"<div><div>Nasal implants have emerged as a pioneering technology for nasal drug delivery systems. These are breakthrough options made of biocompatible materials that are temporarily inserted into the nasal passages for both functional and cosmetic purposes. Drug-eluting nasal implants are beneficial for improving patient compliance, reducing the need for repeated drug administration, and achieving controlled release of therapeutic agents. This article offers a comprehensive insight into nasal implants and their applications, and addresses a patent perspective in the same context. Important considerations for clinically approved implants, such as Propel, Sinuva, Sinu-Foam, and Relieva Stratus, have also been discussed.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 217-220"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143226614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Errata regarding previously published articles 有关以前发表的文章的勘误
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.12.002
{"title":"Errata regarding previously published articles","authors":"","doi":"10.1016/j.cjprs.2023.12.002","DOIUrl":"10.1016/j.cjprs.2023.12.002","url":null,"abstract":"","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 223-224"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139458403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of mild and moderate congenital ptosis via the levator imbrication technique 通过提上睑肌腱膜固定技术治疗轻度和中度先天性上睑下垂
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.12.005
Feixue Ding , Xuran Zhu , Li Yang

Background

To correct mild and moderate congenital ptosis, traditional surgical techniques usually include dissection of the Müller’s muscle. Meanwhile, both the levator palpebrae superioris and the Müller’s muscle play a synergistic role to elevate the upper eyelid. Thus, to protect the Müller muscle and minimize injury, we developed and applied a levator imbrication technique in patients with mild and moderate congenital ptosis and followed it up to evaluate its clinical efficacy.

Methods

This retrospective case series included 53 patients with mild and moderate congenital ptosis, all of whom had undergone ptosis correction using the levator imbrication technique at the Plastic and Aesthetic Department of the Second Affiliated Hospital of Zhengzhou University between June 2018 and June 2020. The outcomes of correction, upper eyelid appearance, and operative complications were observed and analyzed. The postoperative follow-up was 3–12 months.

Results

Fifty cases of ptosis were fully corrected, and the bilateral double eyelids were smooth and natural. The eyelids of 20 patients were incompletely closed immediately after the operation but were able to close spontaneously within 2 weeks. No serious complications such as exposure keratitis were reported. Three patients with undercorrection underwent reoperation 3 months after the first operation, and ptosis was corrected.

Conclusion

The levator imbrication technique for mild and moderate congenital ptosis is simple to perform and shortens the operation time with less damage, stable postoperative outcomes, and no long-term complications.
背景:为了矫正轻度和中度先天性上睑下垂,传统的手术技术通常包括切除臀肌。同时提上睑肌和勒肌协同作用提升上睑。因此,为了保护腘绳肌,减少损伤,我们开发并应用提上睑肌叠瓦术治疗轻、中度先天性上睑下垂患者,并随访评估其临床疗效。方法回顾性分析2018年6月至2020年6月在郑州大学第二附属医院整形美容科行轻、中度先天性上睑下垂矫治术的患者53例。观察和分析手术后的矫正效果、上睑外观及手术并发症。术后随访3-12个月。结果50例上睑下垂完全矫正,双侧双眼皮光滑自然。20例患者术后眼睑未完全闭合,但在2周内自发闭合。未见暴露性角膜炎等严重并发症。3例矫正不足患者在第一次手术后3个月再次手术,上睑下垂得到矫正。结论提上睑肌叠瓦术治疗轻、中度先天性上睑下垂操作简单,手术时间短,损伤小,术后效果稳定,无远期并发症。
{"title":"Treatment of mild and moderate congenital ptosis via the levator imbrication technique","authors":"Feixue Ding ,&nbsp;Xuran Zhu ,&nbsp;Li Yang","doi":"10.1016/j.cjprs.2023.12.005","DOIUrl":"10.1016/j.cjprs.2023.12.005","url":null,"abstract":"<div><h3>Background</h3><div>To correct mild and moderate congenital ptosis, traditional surgical techniques usually include dissection of the Müller’s muscle. Meanwhile, both the levator palpebrae superioris and the Müller’s muscle play a synergistic role to elevate the upper eyelid. Thus, to protect the Müller muscle and minimize injury, we developed and applied a levator imbrication technique in patients with mild and moderate congenital ptosis and followed it up to evaluate its clinical efficacy.</div></div><div><h3>Methods</h3><div>This retrospective case series included 53 patients with mild and moderate congenital ptosis, all of whom had undergone ptosis correction using the levator imbrication technique at the Plastic and Aesthetic Department of the Second Affiliated Hospital of Zhengzhou University between June 2018 and June 2020. The outcomes of correction, upper eyelid appearance, and operative complications were observed and analyzed. The postoperative follow-up was 3–12 months.</div></div><div><h3>Results</h3><div>Fifty cases of ptosis were fully corrected, and the bilateral double eyelids were smooth and natural. The eyelids of 20 patients were incompletely closed immediately after the operation but were able to close spontaneously within 2 weeks. No serious complications such as exposure keratitis were reported. Three patients with undercorrection underwent reoperation 3 months after the first operation, and ptosis was corrected.</div></div><div><h3>Conclusion</h3><div>The levator imbrication technique for mild and moderate congenital ptosis is simple to perform and shortens the operation time with less damage, stable postoperative outcomes, and no long-term complications.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 173-177"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139392656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances and established therapies in linear scar prevention 线性疤痕预防方面的进展和成熟疗法
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.12.003
Jingjing Sun, Yajing Qiu, Xiaoxi Lin
Linear scars are scars formed after surgery or other trauma-healing procedures that typically exhibit a linear morphology. Optimal linear scars are characterized by narrowness, flatness, and a color closely resembling the adjacent tissue. Failure to meet these criteria can have detrimental effects on the physical and psychological well-being of patients. Thus, early intervention for linear scars can effectively improve functionality and aesthetics. This review aimed to consolidate the prevailing agreement on scar prevention therapies and provide clinical physicians with comprehensive and cutting-edge guidance.
线性疤痕是在手术或其他创伤愈合过程后形成的疤痕,通常表现为线性形态。最佳线性疤痕的特点是狭窄、平坦,颜色与邻近组织非常相似。不符合这些标准会对患者的身心健康产生不利影响。因此,线性疤痕的早期干预可以有效地改善功能和美观。本综述旨在巩固对瘢痕预防治疗的普遍共识,并为临床医生提供全面和前沿的指导。
{"title":"Advances and established therapies in linear scar prevention","authors":"Jingjing Sun,&nbsp;Yajing Qiu,&nbsp;Xiaoxi Lin","doi":"10.1016/j.cjprs.2023.12.003","DOIUrl":"10.1016/j.cjprs.2023.12.003","url":null,"abstract":"<div><div>Linear scars are scars formed after surgery or other trauma-healing procedures that typically exhibit a linear morphology. Optimal linear scars are characterized by narrowness, flatness, and a color closely resembling the adjacent tissue. Failure to meet these criteria can have detrimental effects on the physical and psychological well-being of patients. Thus, early intervention for linear scars can effectively improve functionality and aesthetics. This review aimed to consolidate the prevailing agreement on scar prevention therapies and provide clinical physicians with comprehensive and cutting-edge guidance.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 212-216"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139195090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eyelid reconstruction methods: A 10-year review 眼睑重建方法:十年回顾
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.11.001
Maria Cervatiuc , Igor Vladimirovich Reshetov , Svetlana Vagovna Saakyan , Eldor Jonnazarov , Larisa Viktorovna Shklyaruk , Nodirbek Ulugbekovich Dzhapiev , Bashirkhon Ahmadkhojaevich Tursunov
In ophthalmological practice, eyelid reconstruction is often needed because of the presence of defects that arise after the excision of a tumor or after injuries. Various methods for reconstructing these defects have been previously described. However, it is important to understand the basic principles underlying these techniques and their advantages and disadvantages to ensure the choice of the optimal technique in a particular case. We have analyzed the recent literature on new methods or modifications of existing ones to provide a brief overview of the reconstructive methods of the century for comparison. We searched PubMed and CyberLeninka for articles on restoring eyelid defects reported in the literature over the past 10 years. Most techniques can be considered modified classical reconstruction methods. Postoperative complications included aesthetic defects, such as scarring of the upper or lower eyelid, trichiasis, entropion, and lagophthalmos. Surgeons continue to search for the best methods for complex reconstructive surgery to achieve good cosmetic and aesthetic outcomes.
在眼科实践中,由于肿瘤切除或损伤后出现缺陷,经常需要眼睑重建。重建这些缺陷的各种方法已经在前面描述过。然而,重要的是要了解这些技术的基本原理及其优缺点,以确保在特定情况下选择最佳技术。我们分析了最近关于新方法或现有方法的修改的文献,以提供本世纪重建方法的简要概述,以便进行比较。我们检索了PubMed和CyberLeninka在过去十年中报道的关于修复眼睑缺陷的文章。大多数技术可以看作是对经典重建方法的改进。术后并发症包括美观缺陷,如上眼睑或下眼睑瘢痕、倒睫、内翻和眼lagimos。外科医生继续寻找最好的方法,复杂的重建手术,以达到良好的美容和美学效果。
{"title":"Eyelid reconstruction methods: A 10-year review","authors":"Maria Cervatiuc ,&nbsp;Igor Vladimirovich Reshetov ,&nbsp;Svetlana Vagovna Saakyan ,&nbsp;Eldor Jonnazarov ,&nbsp;Larisa Viktorovna Shklyaruk ,&nbsp;Nodirbek Ulugbekovich Dzhapiev ,&nbsp;Bashirkhon Ahmadkhojaevich Tursunov","doi":"10.1016/j.cjprs.2023.11.001","DOIUrl":"10.1016/j.cjprs.2023.11.001","url":null,"abstract":"<div><div>In ophthalmological practice, eyelid reconstruction is often needed because of the presence of defects that arise after the excision of a tumor or after injuries. Various methods for reconstructing these defects have been previously described. However, it is important to understand the basic principles underlying these techniques and their advantages and disadvantages to ensure the choice of the optimal technique in a particular case. We have analyzed the recent literature on new methods or modifications of existing ones to provide a brief overview of the reconstructive methods of the century for comparison. We searched PubMed and CyberLeninka for articles on restoring eyelid defects reported in the literature over the past 10 years. Most techniques can be considered modified classical reconstruction methods. Postoperative complications included aesthetic defects, such as scarring of the upper or lower eyelid, trichiasis, entropion, and lagophthalmos. Surgeons continue to search for the best methods for complex reconstructive surgery to achieve good cosmetic and aesthetic outcomes.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 205-211"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139302902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
History and prospect of melanocytic nevus treatment: A bibliometric analysis 黑素细胞痣治疗的历史与展望:文献计量学分析
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.10.001
Zizhen Guo , Lingling Ge , Yuehua Li , Yihui Gu, Wei Wang, Chengjiang Wei, Bin Gu, Qingfeng Li, Zhichao Wang

Background

Melanocytic nevus is mainly treated by complete or partial removal. However, predicting the risk of malignant transformation of melanocytic nevi and which treatment patients should receive, surgical or non-surgical management, to gain the best results and aesthetic outcomes is controversial.

Methods

Global literature on melanocytic nevus treatment, published between 1997 and 2022, was scanned using the Web of Science Core Collection database. Microsoft Office Excel, CiteSpace V, VOSviewer, Scimago Graphica, Bibliometrix, and Biblioshiny packages in R were used for the bibliometric analysis to summarize the leading countries, institutions, professors, and research trends in this field.

Results

This study included 1 723 articles. Publications and citations exhibited positive trends over the past 20 years. The United States had the most productive organizations and publications in the comprehensive worldwide cooperation network, and China was recently one of the most active major participants. Professor Giovanni Pellacani, whose H-index, G-index, and M-index ranked first in this field, founded a virtual biopsy using reflectance confocal microscopy. In addition, Krengel and Kinsler contributed significantly to diagnosing and treating melanocytic nevi. The top 25 keywords in recent years were mostly about the mechanisms and risk factors for the malignant transformation of nevi.

Conclusion

The future trend for melanocytic nevi treatment is to specify genotype-phenotype and genotype-outcome correlations, choose proper therapy to reduce the risk of malignant transformation, and simultaneously achieve the best aesthetic outcomes.
黑素细胞痣主要通过完全或部分切除来治疗。然而,预测黑素细胞痣恶性转化的风险以及患者应该接受哪种治疗,手术或非手术治疗,以获得最佳效果和美观效果是有争议的。方法使用Web of Science Core Collection数据库对1997年至2022年间发表的关于黑素细胞痣治疗的全球文献进行扫描。使用Microsoft Office Excel、CiteSpace V、VOSviewer、Scimago Graphica、Bibliometrix、Biblioshiny等软件包进行文献计量学分析,总结该领域的主要国家、机构、教授和研究趋势。结果纳入文献1 723篇。在过去的20年里,出版物和引用呈现出积极的趋势。在这一全面的全球合作网络中,美国拥有最富有成效的组织和出版物,而中国最近是最活跃的主要参与者之一。h指数、g指数和m指数在该领域排名第一的Giovanni Pellacani教授发明了利用反射共聚焦显微镜的虚拟活检。此外,Krengel和Kinsler对黑素细胞痣的诊断和治疗也做出了重要贡献。近年来排名前25位的关键词多为痣恶性转化的机制及危险因素。结论明确基因型-表型和基因型-预后的相关性,选择合适的治疗方法,降低恶性转化的风险,同时达到最佳的美容效果是黑素细胞痣治疗的未来趋势。
{"title":"History and prospect of melanocytic nevus treatment: A bibliometric analysis","authors":"Zizhen Guo ,&nbsp;Lingling Ge ,&nbsp;Yuehua Li ,&nbsp;Yihui Gu,&nbsp;Wei Wang,&nbsp;Chengjiang Wei,&nbsp;Bin Gu,&nbsp;Qingfeng Li,&nbsp;Zhichao Wang","doi":"10.1016/j.cjprs.2023.10.001","DOIUrl":"10.1016/j.cjprs.2023.10.001","url":null,"abstract":"<div><h3>Background</h3><div>Melanocytic nevus is mainly treated by complete or partial removal. However, predicting the risk of malignant transformation of melanocytic nevi and which treatment patients should receive, surgical or non-surgical management, to gain the best results and aesthetic outcomes is controversial.</div></div><div><h3>Methods</h3><div>Global literature on melanocytic nevus treatment, published between 1997 and 2022, was scanned using the Web of Science Core Collection database. Microsoft Office Excel, CiteSpace V, VOSviewer, Scimago Graphica, Bibliometrix, and Biblioshiny packages in R were used for the bibliometric analysis to summarize the leading countries, institutions, professors, and research trends in this field.</div></div><div><h3>Results</h3><div>This study included 1 723 articles. Publications and citations exhibited positive trends over the past 20 years. The United States had the most productive organizations and publications in the comprehensive worldwide cooperation network, and China was recently one of the most active major participants. Professor Giovanni Pellacani, whose H-index, G-index, and M-index ranked first in this field, founded a virtual biopsy using reflectance confocal microscopy. In addition, Krengel and Kinsler contributed significantly to diagnosing and treating melanocytic nevi. The top 25 keywords in recent years were mostly about the mechanisms and risk factors for the malignant transformation of nevi.</div></div><div><h3>Conclusion</h3><div>The future trend for melanocytic nevi treatment is to specify genotype-phenotype and genotype-outcome correlations, choose proper therapy to reduce the risk of malignant transformation, and simultaneously achieve the best aesthetic outcomes.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 163-172"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136093280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salvage anastomosis in free PAP-flap breast reconstruction: What about free flap neovascularization? 游离 PAP 瓣乳房重建中的挽救性吻合:游离皮瓣新生血管怎么办?
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.12.001
Michaël Hepp, Aline Berners, Christine Deconinck, Genevieve Pirson, Maxime Servaes, Philippe Fosseprez
Since the emergence of microsurgery in reconstructive surgery, free flaps have become a key tool in the management of patients with breast cancer. One such flap is the profunda artery perforator (PAP) flap. To date, there is no scientific consensus on whether voluminous free flaps remain dependent on their vascular pedicle throughout their lifespan. Therefore, the pedicle should always be carefully protected during revision surgery. In this article, we review the case of a middle-aged woman who suffered a pedicle transection needing re-anastomosis during revision surgery six months after free-flap breast reconstruction. A 52-year-old woman who noticed a firm nodule in her right breast and armpit was referred to our department for surgical management. The Caucasian woman presented with no significant medical history or symptoms at the first consultation. Ultrasound-guided biopsy confirmed an invasive grade III lobular carcinoma. Following staging, the patient underwent neoadjuvant chemotherapy before a right mastectomy with a complete homolateral axillary lymph node dissection and postoperative radiotherapy. One year after completing radiotherapy, free flap reconstruction with a PAP flap was performed, and six months later, revision surgery was required to enhance the volume of the reconstructed breast with a tissue expander and later an implant. Unfortunately, pedicle transection occurred during revision surgery, causing complete devascularization of the flap, which was confirmed by intraoperative Indocyanine Green imaging. The authors elected to perform salvage re-anastomosis during the surgery. In keeping with the author’s 23-year experience with free flaps, the vascular pedicle should always be preserved in voluminous free flaps, as neovascularization alone may not ensure whole flap survival. The authors suggest always attempting re-anastomosis if vessels are compromised during revision surgery.
自显微外科在重建手术中出现以来,游离皮瓣已成为乳腺癌患者治疗的关键工具。其中一个皮瓣是深动脉穿支(PAP)皮瓣。迄今为止,没有科学共识的体积自由皮瓣是否仍然依赖于血管蒂在其整个生命周期。因此,翻修手术时应小心保护椎弓根。在这篇文章中,我们回顾了一个中年妇女在自由皮瓣乳房重建六个月后的翻修手术中遭受椎弓根横断需要重新吻合的病例。一名52岁女性因右乳及腋窝有一硬结节而转介至我科接受手术治疗。该高加索妇女首次就诊时无明显病史或症状。超声引导下活检证实为浸润性III级小叶癌。根据分期,患者在右侧乳房切除术前接受了新辅助化疗,并进行了完全的同侧腋窝淋巴结清扫和术后放疗。放疗结束一年后,采用PAP皮瓣进行自由皮瓣重建,6个月后,需要进行翻修手术,用组织扩张器增加重建乳房的体积,然后植入。不幸的是,翻修手术中发生了蒂横断,导致皮瓣完全断流,术中吲哚菁绿成像证实了这一点。作者选择术中行挽救性再吻合。根据作者23年自由皮瓣的经验,血管蒂应始终保留在大体积的自由皮瓣中,因为单独的新生血管可能无法确保整个皮瓣的存活。作者建议,如果在翻修手术中血管受损,总是尝试再吻合。
{"title":"Salvage anastomosis in free PAP-flap breast reconstruction: What about free flap neovascularization?","authors":"Michaël Hepp,&nbsp;Aline Berners,&nbsp;Christine Deconinck,&nbsp;Genevieve Pirson,&nbsp;Maxime Servaes,&nbsp;Philippe Fosseprez","doi":"10.1016/j.cjprs.2023.12.001","DOIUrl":"10.1016/j.cjprs.2023.12.001","url":null,"abstract":"<div><div>Since the emergence of microsurgery in reconstructive surgery, free flaps have become a key tool in the management of patients with breast cancer. One such flap is the profunda artery perforator (PAP) flap. To date, there is no scientific consensus on whether voluminous free flaps remain dependent on their vascular pedicle throughout their lifespan. Therefore, the pedicle should always be carefully protected during revision surgery. In this article, we review the case of a middle-aged woman who suffered a pedicle transection needing re-anastomosis during revision surgery six months after free-flap breast reconstruction. A 52-year-old woman who noticed a firm nodule in her right breast and armpit was referred to our department for surgical management. The Caucasian woman presented with no significant medical history or symptoms at the first consultation. Ultrasound-guided biopsy confirmed an invasive grade III lobular carcinoma. Following staging, the patient underwent neoadjuvant chemotherapy before a right mastectomy with a complete homolateral axillary lymph node dissection and postoperative radiotherapy. One year after completing radiotherapy, free flap reconstruction with a PAP flap was performed, and six months later, revision surgery was required to enhance the volume of the reconstructed breast with a tissue expander and later an implant. Unfortunately, pedicle transection occurred during revision surgery, causing complete devascularization of the flap, which was confirmed by intraoperative Indocyanine Green imaging. The authors elected to perform salvage re-anastomosis during the surgery. In keeping with the author’s 23-year experience with free flaps, the vascular pedicle should always be preserved in voluminous free flaps, as neovascularization alone may not ensure whole flap survival. The authors suggest always attempting re-anastomosis if vessels are compromised during revision surgery.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 178-181"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139193221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasal valve angle or nasal valve groove: Which is more suitable to describe a normal anatomic structure? 鼻瓣角或鼻瓣沟:哪个更适合描述正常解剖结构?
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.11.003
Baofu Yu, Chuanchang Dai, Jiao Wei
The size of the nasal valve angle is often used to assess nasal ventilation. A larger angle of the nasal valve is believed to be more conducive for ventilation, and a small angle is considered unfavorable. However, in more than 30 years of clinical practice, we have experienced that some patients with a normal nasal valve angle have relatively severe subjective or objective nasal ventilation obstruction. By studying the computed tomography data of these patients, we found that the tips of their nasal valves were at a sharp angle, while those of healthy individuals were in an arc shape. A sharp angle at the tip of the nasal valve, therefore, is a risk factor for obstructed nasal ventilation. Herein, we propose that the term “nasal valve groove” may be a more appropriate descriptor for the normal internal nasal valve anatomy, and we hope that more rhinoplasty surgeons will pay attention to how the shape of the tip affects nasal ventilation.
鼻阀角度的大小常用于评估鼻通气。鼻阀角度较大被认为更有利于通气,而角度较小则被认为不利。然而,在30多年的临床实践中,我们经历过一些鼻阀角度正常的患者主观或客观存在较为严重的鼻通气阻塞。通过研究这些患者的计算机断层扫描数据,我们发现他们的鼻阀尖端呈锐角,而健康个体的鼻阀尖端呈弧形。因此,鼻阀尖端的锐角是鼻腔通气受阻的危险因素。在此,我们建议“鼻阀沟”可能是一个更合适的描述正常内鼻阀解剖结构的术语,我们希望更多的鼻整形外科医生关注鼻尖形状如何影响鼻通气。
{"title":"Nasal valve angle or nasal valve groove: Which is more suitable to describe a normal anatomic structure?","authors":"Baofu Yu,&nbsp;Chuanchang Dai,&nbsp;Jiao Wei","doi":"10.1016/j.cjprs.2023.11.003","DOIUrl":"10.1016/j.cjprs.2023.11.003","url":null,"abstract":"<div><div>The size of the nasal valve angle is often used to assess nasal ventilation. A larger angle of the nasal valve is believed to be more conducive for ventilation, and a small angle is considered unfavorable. However, in more than 30 years of clinical practice, we have experienced that some patients with a normal nasal valve angle have relatively severe subjective or objective nasal ventilation obstruction. By studying the computed tomography data of these patients, we found that the tips of their nasal valves were at a sharp angle, while those of healthy individuals were in an arc shape. A sharp angle at the tip of the nasal valve, therefore, is a risk factor for obstructed nasal ventilation. Herein, we propose that the term “nasal valve groove” may be a more appropriate descriptor for the normal internal nasal valve anatomy, and we hope that more rhinoplasty surgeons will pay attention to how the shape of the tip affects nasal ventilation.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 221-222"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143226615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of complete lymph node dissection in patients with melanoma: A systemic review and meta-analysis 黑色素瘤患者完全淋巴结清扫的评估:系统回顾和荟萃分析
Pub Date : 2023-12-01 DOI: 10.1016/j.cjprs.2023.11.004
Jiangying Xuan , Ming Zhu , Lu Wang, Zixu Gao, Kangjie Shen, Ming Ren, Yanlin Li, Chuanyuan Wei, Jianying Gu

Background

Complete lymph node dissection (CLND) for patients with melanoma remains controversial. This meta-analysis aimed to compare the prognoses and complications between the CLND and control groups (patients who receive adjuvant treatment or observation only) in patients with sentinel lymph node (SLN)-positive melanoma.

Methods

The PubMed, Embase, Cochrane, and Web of Science databases were searched for cohort studies and randomized clinical trials (RCTs) conducted between 1964 and 2022, and the quality of the studies was assessed using the Cochrane risk-of-bias tool and Newcastle-Ottawa Scale. Hazard ratios (HR) or risk ratios (RR) with 95% confidence intervals (CIs) were calculated for each outcome. Heterogeneity and sensitivity tests were also conducted, and publication bias tests were performed when the pooled number of studies was >10.

Results

Fifteen studies, including 11 cohort studies and 4 RCTs, were enrolled and assessed for quality. Analysis of overall survival showed no significant difference between the CLND and control groups (HR=1.02, 95% CI: 0.69–1.51, P=0.922). Similarly, recurrence-free survival (HR=0.84, 95% CI: 0.6–1.16, P=0.287), disease-free survival (HR=1.06, 95% CI: 0.65–1.72, P=0.82), and disease-specific survival (HR=0.84, 95% CI: 0.59–1.21, P=0.355) showed no difference between the two groups. CLND did not reduce the risk of recurrence (RR=0.98, 95% CI: 0.8–1.2, P=0.851).

Conclusion

Remarkably, patients who underwent CLND were more likely to have complications such as flap necrosis and lymphedema than the controls. CLND does not improve patient prognosis and may increase the incidence of complications.
背景:完全淋巴结清扫(CLND)对黑色素瘤患者的治疗仍然存在争议。本荟萃分析旨在比较前哨淋巴结(SLN)阳性黑色素瘤患者的CLND组和对照组(接受辅助治疗或仅观察的患者)的预后和并发症。方法检索PubMed、Embase、Cochrane和Web of Science数据库,检索1964年至2022年间进行的队列研究和随机临床试验(rct),并使用Cochrane风险偏倚工具和纽卡斯尔-渥太华量表评估研究的质量。计算每个结果的风险比(HR)或风险比(RR), 95%可信区间(CIs)。并进行异质性和敏感性检验,当合并研究数为>;10时,进行发表偏倚检验。结果纳入了15项研究,包括11项队列研究和4项随机对照试验,并对质量进行了评估。总生存率分析显示,CLND组与对照组之间无显著差异(HR=1.02, 95% CI: 0.69-1.51, P=0.922)。同样,两组无复发生存率(HR=0.84, 95% CI: 0.6-1.16, P=0.287)、无疾病生存率(HR=1.06, 95% CI: 0.65-1.72, P=0.82)和疾病特异性生存率(HR=0.84, 95% CI: 0.59-1.21, P=0.355)均无差异。CLND未降低复发风险(RR=0.98, 95% CI: 0.8 ~ 1.2, P=0.851)。结论与对照组相比,行CLND的患者更容易出现皮瓣坏死、淋巴水肿等并发症。CLND不能改善患者预后,并可能增加并发症的发生率。
{"title":"Assessment of complete lymph node dissection in patients with melanoma: A systemic review and meta-analysis","authors":"Jiangying Xuan ,&nbsp;Ming Zhu ,&nbsp;Lu Wang,&nbsp;Zixu Gao,&nbsp;Kangjie Shen,&nbsp;Ming Ren,&nbsp;Yanlin Li,&nbsp;Chuanyuan Wei,&nbsp;Jianying Gu","doi":"10.1016/j.cjprs.2023.11.004","DOIUrl":"10.1016/j.cjprs.2023.11.004","url":null,"abstract":"<div><h3>Background</h3><div>Complete lymph node dissection (CLND) for patients with melanoma remains controversial. This meta-analysis aimed to compare the prognoses and complications between the CLND and control groups (patients who receive adjuvant treatment or observation only) in patients with sentinel lymph node (SLN)-positive melanoma.</div></div><div><h3>Methods</h3><div>The PubMed, Embase, Cochrane, and Web of Science databases were searched for cohort studies and randomized clinical trials (RCTs) conducted between 1964 and 2022, and the quality of the studies was assessed using the Cochrane risk-of-bias tool and Newcastle-Ottawa Scale. Hazard ratios (HR) or risk ratios (RR) with 95% confidence intervals (CIs) were calculated for each outcome. Heterogeneity and sensitivity tests were also conducted, and publication bias tests were performed when the pooled number of studies was &gt;10.</div></div><div><h3>Results</h3><div>Fifteen studies, including 11 cohort studies and 4 RCTs, were enrolled and assessed for quality. Analysis of overall survival showed no significant difference between the CLND and control groups (HR=1.02, 95% CI: 0.69–1.51, <em>P</em>=0.922). Similarly, recurrence-free survival (HR=0.84, 95% CI: 0.6–1.16, <em>P</em>=0.287), disease-free survival (HR=1.06, 95% CI: 0.65–1.72, <em>P</em>=0.82), and disease-specific survival (HR=0.84, 95% CI: 0.59–1.21, <em>P</em>=0.355) showed no difference between the two groups. CLND did not reduce the risk of recurrence (RR=0.98, 95% CI: 0.8–1.2, <em>P</em>=0.851).</div></div><div><h3>Conclusion</h3><div>Remarkably, patients who underwent CLND were more likely to have complications such as flap necrosis and lymphedema than the controls. CLND does not improve patient prognosis and may increase the incidence of complications.</div></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 4","pages":"Pages 195-204"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143226613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Journal of Plastic and Reconstructive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1